Catalyst Wire Dossier Catalyst Wire Dossier

Nevirapine IR

nevirapine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nevirapine IR, covering 2012-01-19 to 2012-01-19. Get the full timeline:

Most recent: Clinical Trial Update: VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients [Phase 3]

See pricing